Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00151138 · ClinicalTrials.gov registry record · NA
Cognitive/Cerebrovascular Consequences of HTN Treatment
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00151138: Completed NA study, sponsored by University of Pittsburgh.
NCT00151138 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00151138, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Randomized trial of two antihypertensive drugs of known efficacy to investigate whether one has more favorable effects on brain blood flow and cognitive function.
Interventions
- DRUG Atenolol (drug), Lisinopril (drug)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2002-09 |
| Est. Completion | 2007-05 |
| Phase | NA |
What the finished NCT00151138 record still lists
NCT00151138 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Atenolol (drug), Lisinopril (drug) is the first listed.
NCT00151138 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00151138 about?
NCT00151138 is a clinical study titled "Cognitive/Cerebrovascular Consequences of HTN Treatment". Randomized trial of two antihypertensive drugs of known efficacy to investigate whether one has more favorable effects on brain blood flow and cognitive function.
What is the current status of trial NCT00151138?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2002-09. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00151138?
The interventions under investigation include: Atenolol (drug), Lisinopril (drug) (DRUG).
Who is sponsoring clinical trial NCT00151138?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00151138's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia